Welcome to MutualFunds.com. Please help us personalize your experience.
Your personalized experience is almost ready.
Thank you!
Check your email and confirm your subscription to complete your personalized experience.
Thank you for your submission, we hope you enjoy your experience
Find the latest content and information here about the 2019 Charles Schwab Impact Conference.
18 Most Popular Mutual Fund Categories
View All Categories
15 Most Popular Fund Company Quick Screens
View All Fund Company Quick Screens
Receive email updates about fund flows, news, upcoming CE accredited webcasts from industry thought leaders and more.
Content focused on helping financial advisors build successful client relationships and grow their business.
Content geared towards helping financial advisors build better client portfolios.
Get insights on the industry trends and investment news from leading fund managers and experts.
Fidelity Select Biotechnology Portfolio (FBIOX) is an actively managed mutual fund managed by Fidelity. The fund is focused primarily on the biotechnology industry and its operations. It is compiled primarily of U.S. common stocks in the healthcare industry with some exposure to the services industries. In general, this fund tends to have 80% of its holdings in stocks that are focused in research, development, manufacturing, and distribution of biotechnological products, services, processes and companies. The fund has been managed by Rajiv Kaul since 2005 and was launched on December 16, 1985.
The fund is very focused on capital appreciation but carries a higher amount of risk since it is sector-focused and has little diversification. The fund holds additional risk since the companies are affected by patent considerations, high competition, technological changes and government regulations. Despite its risk, the biotechnology industry is well known for its high risk and reward and may be ideal for aggressive investors seeking growth and high returns in their portfolio. In addition, sector based mutual funds such as the Fidelity Select Biotechnology Portfolio may be a good alternative for investors seeking exposure to the biotechnology industry without buying specific stocks.
Holdings in this fund are generally large cap growth stocks. The fund’s holdings are determined by analyzing drug pipelines, the size of market opportunities and the valuations. Typically, this fund holds long term growth stocks, companies with attractive drug pipelines, turnaround companies, breakthrough companies and startups.
The fund’s holdings are chosen by using various factors including financial conditions, industry position, and current economic and market conditions. This fund aims to outperform the benchmark through its active management. The fund pays dividends and capital gains every year in April and December.
This fund requires a minimum initial investment of $2,500 for both regular and IRA accounts.
Sign up for Advisor Access to receive email updates about FBIOX competitors, news, CE accredited webcasts and more.
| Period | FBIOX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | 1.6% | 0.0% | 6.1% | 73.64% |
| 1 Yr | 11.6% | 2.6% | 41.8% | 75.63% |
| 3 Yr | 6.5%* | -9.3% | 27.6% | 75.23% |
| 5 Yr | -0.7%* | -9.8% | 14.7% | 76.42% |
| 10 Yr | 12.8%* | -0.8% | 18.8% | 27.47% |
* Annualized
| Period | FBIOX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2019 | 24.5% | 5.7% | 55.4% | 21.85% |
| 2018 | -19.1% | -25.3% | 21.5% | 92.79% |
| 2017 | 26.1% | -10.8% | 43.9% | 11.93% |
| 2016 | -26.2% | -31.6% | 6.9% | 96.23% |
| 2015 | 6.6% | -20.4% | 13.8% | 9.71% |
| Period | FBIOX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | 1.6% | 0.0% | 6.1% | 73.64% |
| 1 Yr | 11.6% | 2.6% | 41.8% | 75.63% |
| 3 Yr | 8.5%* | -9.3% | 30.8% | 71.56% |
| 5 Yr | 2.4%* | -9.8% | 16.7% | 69.81% |
| 10 Yr | 16.8%* | -0.5% | 18.8% | 12.09% |
* Annualized
| Period | FBIOX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2019 | 24.5% | 5.7% | 55.4% | 21.85% |
| 2018 | -15.8% | -25.3% | 22.2% | 87.39% |
| 2017 | 27.9% | -10.8% | 45.8% | 11.01% |
| 2016 | -23.8% | -26.4% | 8.7% | 94.34% |
| 2015 | 13.9% | -16.6% | 15.2% | 4.85% |
| FBIOX | Category Low | Category High | FBIOX % Rank | |
|---|---|---|---|---|
| Net Assets | 7.26 B | 3.58 M | 48.1 B | 10.24% |
| Number of Holdings | 241 | 18 | 399 | 2.33% |
| Net Assets in Top 10 | 2.6 B | 71.5 K | 17.4 B | 10.85% |
| Weighting of Top 10 | 36.86% | 21.3% | 75.3% | 65.12% |
| Weighting | Return Low | Return High | FBIOX % Rank | |
|---|---|---|---|---|
| Stocks | 96.71% | 48.12% | 103.54% | 79.84% |
| Other | 1.97% | -27.41% | 5.17% | 6.20% |
| Cash | 1.10% | 0.00% | 51.88% | 46.51% |
| Preferred Stocks | 0.21% | 0.00% | 1.08% | 13.18% |
| Convertible Bonds | 0.00% | 0.00% | 1.54% | 68.99% |
| Bonds | 0.00% | 0.00% | 20.60% | 65.89% |
| Weighting | Return Low | Return High | FBIOX % Rank | |
|---|---|---|---|---|
| Healthcare | 100.00% | 58.44% | 100.00% | 20.93% |
| Utilities | 0.00% | 0.00% | 0.00% | 62.79% |
| Technology | 0.00% | 0.00% | 16.36% | 75.19% |
| Real Estate | 0.00% | 0.00% | 5.84% | 67.44% |
| Industrials | 0.00% | 0.00% | 2.40% | 65.89% |
| Financial Services | 0.00% | 0.00% | 6.09% | 67.44% |
| Energy | 0.00% | 0.00% | 0.43% | 65.12% |
| Communication Services | 0.00% | 0.00% | 1.02% | 65.12% |
| Consumer Defense | 0.00% | 0.00% | 36.20% | 65.89% |
| Consumer Cyclical | 0.00% | 0.00% | 10.50% | 65.89% |
| Basic Materials | 0.00% | 0.00% | 2.02% | 71.32% |
| Weighting | Return Low | Return High | FBIOX % Rank | |
|---|---|---|---|---|
| US | 90.11% | 48.12% | 99.93% | 18.60% |
| Non US | 6.60% | 0.00% | 39.36% | 81.40% |
| FBIOX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Expense Ratio | 0.72% | 0.10% | 9.84% | 92.91% |
| Management Fee | 0.54% | 0.09% | 1.30% | 11.63% |
| 12b-1 Fee | N/A | 0.00% | 1.00% | N/A |
| Administrative Fee | N/A | 0.03% | 0.40% | N/A |
| FBIOX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Front Load | N/A | 2.50% | 5.75% | N/A |
| Deferred Load | N/A | 1.00% | 5.00% | N/A |
| FBIOX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Max Redemption Fee | N/A | 1.00% | 2.00% | 95.12% |
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
| FBIOX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Turnover | 37.00% | 0.00% | 341.00% | 54.84% |
| FBIOX | Category Low | Category High | FBIOX % Rank | |
|---|---|---|---|---|
| Dividend Yield | 0.00% | 0.00% | 5.20% | 68.22% |
| FBIOX | Category Low | Category High | Category Mod | |
|---|---|---|---|---|
| Dividend Distribution Frequency | Annually | Annually | Semi-Annually | Annually |
| FBIOX | Category Low | Category High | FBIOX % Rank | |
|---|---|---|---|---|
| Net Income Ratio | -0.20% | -2.24% | 2.12% | 55.91% |
| FBIOX | Category Low | Category High | Capital Mode | |
|---|---|---|---|---|
| Capital Gain Distribution Frequency | Semi-Annually | Annually | Annually | Annually |
Start Date
Tenure
Tenure Rank
Oct 12, 2005
14.23
14.2%
Kaul is a portfolio manager with Fidelity Investments. Since joining Fidelity Investments in 1996, he has worked as a research analyst and portfolio manager. Kaul also manages another Fidelity fund. Prior to Fidelity, Kaul worked at Mckinsey & Company. He is the recipient of the Kann Rasmusson Environment Award, the Dean's Summer Research Award and a Ford Undergraduate Fellowship.
| Category Low | Category High | Category Average | Category Mode |
|---|---|---|---|
| 0.59 | 22.31 | 9.83 | 19.68 |
TAXATION
For mutual fund investors, taxes are inevitable. Even if you’re a long-term buy...
MUTUAL FUND EDUCATION
Many investors assume that changes in a mutual fund’s net asset value (NAV)...
MUTUAL FUND EDUCATION
For investors looking to add mutual funds to their portfolio, they need to...
